Cefotaxime and Curosurf drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cefotaxime (cefotaxime sodium) and Curosurf (poractant alfa). Common drug interactions include necrotising enterocolitis neonatal among females and pneumothorax among males.
The phase IV clinical study analyzes what interactions people have when they take Cefotaxime and Curosurf. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.
What is Cefotaxime?
Cefotaxime has active ingredients of cefotaxime sodium. eHealthMe is studying from 7,559 Cefotaxime users. Check the latest studies of Cefotaxime.
What is Curosurf?
Curosurf has active ingredients of poractant alfa. eHealthMe is studying from 832 Curosurf users. Check the latest studies of Curosurf.
33 people who take Cefotaxime and Curosurf together, and have interactions are studied.

What are the common drug interactions of Cefotaxime and Curosurf, by gender? *:
female:
- Necrotising enterocolitis neonatal (life threatening infection of intestine in newborn baby)
- C-reactive protein increased
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Hypotension (abnormally low blood pressure)
- Pulmonary haemorrhage (acute bleeding from the lung)
- Alveolitis (inflammation in the socket of a tooth)
- Apgar score low
- Bronchopulmonary dysplasia (chronic lung disorder in infants - enlargement of an organ or tissue by the proliferation of cells of an abnormal type)
- Cardiac arrest
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
male:
- Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
- Drug ineffective
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
- Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
- Alveolitis (inflammation in the socket of a tooth)
- Apnoea (suspension of external breathing)
- Bronchopulmonary dysplasia (chronic lung disorder in infants - enlargement of an organ or tissue by the proliferation of cells of an abnormal type)
- Cardiac arrest
- Catheter site related reaction
- Cerebral haemorrhage (bleeding within the brain)
What are the common drug interactions of Cefotaxime and Curosurf, by age (0-1 to 60+)? *:
0-1:
- Necrotising enterocolitis neonatal (life threatening infection of intestine in newborn baby)
- Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
- Hypotension (abnormally low blood pressure)
- Pulmonary haemorrhage (acute bleeding from the lung)
- Vertical infection transmission
- Bradycardia (abnormally slow heart action)
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Hepatomegaly (abnormal enlargement of the liver)
- Hypercapnia (too much smoke)
- Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
n/a
What are the existing conditions these people have? *
- Respiratory Distress Syndrome (Rds) In Infants (respiratory disease of newborn babies, especially premature babies, characterized by distressful breathing, cyanosis, and the formation of a glassy membrane over the alveoli of the lungs): 16 people, 48.48%
- Staphylococcal Sepsis (blood infection by an infection with staphylococcus bacteria): 5 people, 15.15%
- Infection: 5 people, 15.15%
- Respiratory Distress (difficulty in breathing): 2 people, 6.06%
- Hypovolaemia (a decreased volume of circulating blood in the body): 2 people, 6.06%
- High Blood Pressure: 2 people, 6.06%
- Dyspnea (difficult or laboured breathing): 2 people, 6.06%
- Apnea (temporary absence or cessation of breathing): 2 people, 6.06%
* Approximation only. Some reports may have incomplete information.
Do you take Cefotaxime and Curosurf?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Cefotaxime (7,559 reports)
- Curosurf (832 reports)
Browse all drug interactions of Cefotaxime and Curosurf:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cefotaxime:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Curosurf:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cefotaxime and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Curosurf and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cefotaxime sodium and poractant alfa (the active ingredients of Cefotaxime and Curosurf, respectively), and Cefotaxime and Curosurf (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Itraconazole cause Renal Injury? - 14 seconds ago
- Drug interactions of Dymista and Lumigan - 17 seconds ago
- Could Viramune cause Myositis? - 20 seconds ago
- Could Omega-3 Marine Triglycerides cause Vulval Disorder? - 24 seconds ago
- Drug interactions of Tacrolimus and Mydriacyl - 27 seconds ago
- Drug interactions of Endep and Aldactone - 27 seconds ago
- Heparin and Burning Sensation for Women aged 50-59 - 28 seconds ago
- Could Onglyza cause Hiatal Hernia? - 31 seconds ago
- Could Latanoprost cause Coronary Artery Occlusion? - 33 seconds ago
- Drug interactions of Zide and Fiorinal - 35 seconds ago